EcoDrugPlus

Nad(P)h Dehydrogenase [Quinone] 1-Like

Ensembl ID : ENSFHEG00000011299
Gene Symbol: LOC105919406
3 Cross references
180 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSFHEG00000010671
Gene Symbol: NPC1L1
4 Cross references
190 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSFHEG00000000376
Gene Symbol: LOC105932667
3 Cross references
194 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSFHEG00000007144
Gene Symbol: PIM3
3 Cross references
196 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase B

Ensembl ID : ENSFHEG00000001182
Gene Symbol: LOC105940337
3 Cross references
199 Possible Orthologues:

Rac-Gamma Serine/threonine-Protein Kinase

Ensembl ID : ENSFHEG00000019997
Gene Symbol: LOC105927955
3 Cross references
203 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSFHEG00000003029
Gene Symbol: RAF1
3 Cross references
207 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSFHEG00000000654
Gene Symbol: ROCK1
2 Cross references
206 Possible Orthologues:

Sem1 26s Proteasome Complex Subunit

Ensembl ID : ENSFHEG00000012516
Gene Symbol: SEM1
3 Cross references
156 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSFHEG00000012806
Gene Symbol: SRC
4 Cross references
191 Possible Orthologues:

Tgf-Beta Receptor Type-1

Ensembl ID : ENSFHEG00000005756
Gene Symbol: LOC105919548
3 Cross references
205 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSFHEG00000009160
Gene Symbol: TTK
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).